Skip to Main Content

Try STAT+ TODAY

finance

Most Read

Health Tech Mohana Ravindranath

STAT Plus: An investigation into Mindstrong’s unraveling, Cerebral layoffs, and DEA looks to restrict telehealth

Hospitals Tara Bannow

STAT Plus: Ascension, Tufts fall short of financial targets in borrowing agreements

Special Report Mohana Ravindranath

STAT Plus: How Mindstrong’s rush to roll out a ‘smoke alarm’ for mental illness led to its downfall

Hospitals Bob Herman and Tara Bannow

STAT Plus: Hospital systems’ investment income perked up at end of 2022

Health Brittany Trang

The FDA has cleared the first home flu and Covid test — but its maker just declared bankruptcy

Hospitals Bob Herman

Patients still have no protection against surprise ambulance bills. And there’s no solution in sight

Health Tech Casey Ross

STAT Plus: Verily, struggling to turn profits, taps a Starbucks veteran and ‘Warcraft’ master

Health Tech Matthew Herper

STAT Plus: Top Verily executives depart amid leadership shakeup and layoffs

All Coverage

Biotech Adam Feuerstein, Damian Garde and Allison DeAngelis

STAT Plus: SVB, biotech’s bank of choice, just failed. It could have ripple effects

Politics Joanne Silberner

STAT Plus: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices

advertisement

Health Tech Mohana Ravindranath

STAT Plus: In Theranos’s backyard, a health tech leader takes another crack at better blood tests

Hospitals Bob Herman

STAT Plus: In North Carolina, a small hospital deal poses big antitrust questions

Politics Rachel Cohrs

STAT Plus: Medicare advisers suggest tweaks to coverage process for Alzheimer’s drugs

Politics Rachel Cohrs

STAT Plus: Sen. Tammy Baldwin criticizes Ascension’s for-profit investment activities, requests returns and fees info

Hospitals Bob Herman

STAT Plus: What a hospital oligopoly looks like

The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Pharma blockbusters, pandemic policy, & legal chicanery

Biotech Allison DeAngelis

STAT Plus: KKR veteran sets records with $3.9 billion health care fund

Health Tech Brittany Trang

STAT Plus: Alphabet’s laid-off health tech employees on where their work heads next

Biotech Allison DeAngelis

STAT Plus: Focused exclusively on life sciences, three top investors set out on their own

Hospitals Bob Herman

STAT Plus: A different kind of ‘RAC’ subsidized hospitals’ labor during the pandemic

Biotech Allison DeAngelis

STAT Plus: How one private biotech seized on JPM to emerge from stealth and tell its story

Hospitals Bob Herman

STAT Plus: Hospitals gear up to expand market power, raise prices in 2023

Biotech Allison DeAngelis

STAT Plus: Biotech startups are hungry for dollars. Here’s what one pharma executive was looking for at JPM

Politics John Wilkerson

STAT Plus: Medicare paves the way for CAR-T in doctors offices

Biotech Matthew Herper

STAT Plus: Illumina, the DNA sequencing giant, gives Wall Street bad news

Hospitals Tara Bannow

STAT Plus: Medicare Advantage-focused Oak Street, Agilon Health chart out growth at J.P. Morgan

Business Tara Bannow

STAT Plus: Study finds heavier reliance on nurse practitioners, physician assistants after private equity takeovers

Biotech Jonathan Wosen and Allison DeAngelis

STAT Plus: A flurry of pharma acquisitions kick off JPM week after a slow year for deals

Business Bob Herman and Tara Bannow

STAT Plus: The health care providers and insurers we’re watching at JPM23 — and why

Biotech Jonathan Wosen

STAT Plus: Fate Therapeutics plans mass layoffs, after early end to cell therapy deal with Janssen

Health Tech Katie Palmer

STAT Plus: Get care now, pay later?: Health care sees a surge in financing platforms for patients

Business Tara Bannow

STAT Plus: Providers seeking resolution of billing disputes under the No Surprises Act cause a major backlog of cases

Biotech Damian Garde

STAT Plus: Get ready for ‘the electric vehicles of biopharma’: Three biotech trends to watch in 2023